The experimental model of MS can be established either via active immunization with an adjuvant consisting of myelin-derived proteins or peptides, such as myelin basic protein, proteolipid protein, and myelin oligodendrocyte glycoprotein [6,7] or the passive transfer of activated myelin-specific CD4+ T lymphocytes [8]. Here, CD4 is linked to myeloid sarcoma.